Zanidatamab
About
Therapy type: Targeted therapy
Therapy strategy: ER signaling inhibition
Mappings
NCI Thesaurus: Zanidatamab (coding:ncit:C130010)
RxNorm: zanidatamab (coding:rxcui:2698198, coding:omop:1464766)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | HER2-positive | Intraductal Papillary Neoplasm of the Bile Duct | Zanidatamab | |
| FDA (1) | HER2-positive | Intracholecystic Papillary Neoplasm | Zanidatamab | |
| FDA (1) | HER2-positive | Cholangiocarcinoma | Zanidatamab |